Speaker illustration

Associate Professor Takao Kato

Kyoto University Graduate School of Medicine, Kyoto (Japan)

Member of:

European Society of Cardiology

My role is the PI in heart failure lab. The goal of the research is the improvement of the prognosis of heart failure through basic and clinical research. As a post-graduate student, I carried out the comprehensive analyses of metabolic remodeling during the transition of left ventricular hypertrophy to decompensated heart failure in rat model. As a physician-scientist, I feel heart failure is becoming a big medical and social problem in developed countries.

Association of the extent of myocardial ischemia with outcomes in patients with suspected coronary artery disease in Japan: a cohort study

Event: ESC Congress 2021 - The Digital Experience

Topic: Ischaemia and Viability

Session: Nuclear Imaging, Cross-Modality and Multi-Modality Imaging ePosters

Thumbnail

Impact of decreased lymphocyte, total cholesterol, and albumin levels at discharge on all-cause death in patients with acute heart failure

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure e-posters

Thumbnail

Impact of renal dysfunction on choice of diagnostic imaging, treatment strategy, and outcomes in patients with stable angina: a report from J-COMPASS study

Event: ESC Congress 2018

Topic: Noninvasive Diagnostic Methods

Session: Coronary artery disease : diagnosis pharmacotherapy and revascularisation

Thumbnail

Nutritional status in acute decompensated heart failure was closely linked to high in-hospital mortality (from the KCHF registry)

Event: ESC CONGRESS 2017

Topic: AHF - Epidemiology, prognosis and outcome

Session: Acute heart failure (AHF)

Thumbnail

Impact of the left ventricular mass index on the outcomes of conservatively managed severe aortic stenosis: a report from the CURRENT AS registry

Event: ESC CONGRESS 2016

Topic: Aortic valve disease

Session: Valvular disease

Thumbnail

Chronic administration of dehydroepiandrosterone sulfate does not improve survival in rats with hypertensive heart failure

Event: ESC CONGRESS 2016

Topic: Cardiac biology, other

Session: Cardiac genetics and ageing

Thumbnail

This platform is supported by

logo Novo Nordisk